Increasing evidence supports a role for small extracellular vesicles (sEV, including
exosomes) in Diffuse Large B-cell lymphoma (DLBCL) progression and resistance to …

Non-Hodgkin Lymphomas (NHL) represent one of the most common cancers worldwide.
Among the most common forms of NHL are found Chronic Lymphocytic Leukemia (CLL) …

Background Small extracellular vesicles (sEVs) including exosomes, carrying the CD20,
could be involved in immunotherapy resistance in diffuse large B cell lymphoma (DLBCL) …

PD-L1+ exosome have been reported to be a promising prognostic biomarker in various
cancers. However, its clinical value in diffuse large B cell lymphoma (DLBCL) has not been …

Plasma extracellular vesicles (EVs) have been reported to be a promising source of
diagnostic and prognostic biomarkers in various cancers. However, further research in this …

The biological role of extracellular vesicles (EVs) in diffuse large B-cell lymphoma (DLBCL)
initiation and progression remains largely unknown. We characterized EVs secreted by 5 …

Emerging evidence shows that tumor cells secrete extracellular vesicles (EVs) that carry
bioactive cell surface markers, such as programmed death-ligand 1 (PD-L1), which can …

Tumour‐associated macrophages (TAMs) comprise an important part of the tumour
microenvironment and play a key role in malignant tumours progression. Tumour‐derived …

Abstract Background The PD-L1 on tumor cell-derived small extracellular vesicles (sEVs)
can suppress the proliferation and cytokine production of T cells. However, PD-L1 can also …

Extracellular vesicles (EVs), which are generated by cell membrane budding in diverse
cells, are present in variable numbers in the blood. An immunoregulatory role has been …